New Research Finds Phase 3 is the Most Popular Stage for Medical Affairs Teams to Begin Thought Leader Development Activities
08 mai 2017 19h30 HE
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - May 08, 2017) - Between both Phase 3a and 3b, 50% of surveyed teams begin their thought leader development activities, with the next most popular stage to...
Roughly 82% of Pharma Companies Conduct Observational Studies Each Year
27 avr. 2017 09h30 HE
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - April 27, 2017) - The majority (82%) of surveyed drug manufacturers reported conducting -- or planning to conduct -- observational studies last year, which...
Market Access Strategy & Payer Relationships Dominate Average Budget Allocation Among Top 10 & Top 50 Pharma Companies
26 avr. 2017 08h30 HE
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - April 26, 2017) - Surveyed Top 50 companies spend $1.07 million on average for both market access strategy and payer relationships, according to a recent...
Half of Pharma Global Teams' Pharmacovigilance Funding is Contributed by a Standalone Drug Safety Team
25 avr. 2017 07h30 HE
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - April 25, 2017) - On average, half (50%) of surveyed global teams' pharmacovigilance funding is contributed by a standalone drug safety team, according to...
How Pharma Companies Use Digital Marketing and Direct-to-Consumer Advertising During Phase 3
05 avr. 2017 10h14 HE
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - April 05, 2017) - In addition to using medical science liaisons (MSLs) to engage the medical research community, many surveyed pharmaceutical companies have...
Over 60% of Surveyed Pharma Companies Position High-Level Executives to Support KAM Groups
04 avr. 2017 07h45 HE
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - April 04, 2017) - The largest percentage of surveyed pharmaceutical key account management (KAM) teams report to a director, according to a recent...
At Top Global Pharma Companies, Market Access Activities Begin at Least 16 Months Prior to Launch
30 mars 2017 10h18 HE
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - March 30, 2017) - Surveyed Top 10 and Top 50 global companies begin pharmaceutical market access activities on average at least 16 months ahead of product...
Implementing Risk-Based Approaches During Longer Clinical Trials Maximizes Financial Impact
29 mars 2017 18h54 HE
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - March 29, 2017) - Life science firms look to risk-based monitoring (RBM) to reduce costs associated with clinical studies, according to a study by business...
Surveyed Top 50 Pharma and Biotech Companies Report Average Per-Patient Costs of $57,500 During Non-Adaptive Phase 1 Studies
27 mars 2017 19h28 HE
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - March 27, 2017) - Surveyed pharmaceutical, biotech, and device companies expend up to $120,000 per patient during Phase 1 non-adaptive studies, according to...
Average Cost of Training New Medical Information Call Center Agents Tops $16,000
21 mars 2017 10h22 HE
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - March 21, 2017) - The most successful pharmaceutical companies allocate an average $16,900 annually per new call center agent, according to a business...